{"id":193388,"date":"2025-03-28T00:00:00","date_gmt":"2025-03-28T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041069-medtech-cardiac-rhythm-management-devices-market\/"},"modified":"2026-03-31T10:09:59","modified_gmt":"2026-03-31T10:09:59","slug":"47042057-medtech-cardiac-rhythm-management-devices-market-insights-europe","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042057-medtech-cardiac-rhythm-management-devices-market-insights-europe\/","title":{"rendered":"Cardiac Rhythm Management Devices &#8211; Market Insights &#8211; Europe"},"content":{"rendered":"<p>The European <abbr title=\"Cardiac Rhythm Management\">CRM<\/abbr> device market will continue to grow modestly over the forecast period,\u00a0driven primarily by rising <abbr title=\"Insertable Cardiac Monitor\">ICM<\/abbr> procedure volumes, the introduction of dual-chamber leadless pacemakers, and the increasing adoption of premium-priced devices such as <abbr title=\"Cardiac Resynchronization Therapy\">CRT<\/abbr> devices, single-chamber leadless pacemakers, and <abbr data-abbreviation-entity=\"9672\" title=\"Subcutaneous Implantable Cardioverter Defibrillator\">S-<\/abbr><abbr data-abbreviation-entity=\"9672\" title=\"Subcutaneous Implantable Cardioverter Defibrillator\">ICD<\/abbr>s. However, revenue growth will be limited to some extent by <abbr title=\"Average Selling Price\">ASP<\/abbr> declines caused by increasing competition in the leadless pacemaker and <abbr title=\"Subcutaneous Implantable Cardioverter Defibrillator\">S-ICD<\/abbr> markets.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the European <abbr data-abbreviation-entity=\"9036\" title=\"Cardiac Rhythm Management\">CRM<\/abbr> device market from 2019 through 2033.<\/p>\n<p><strong>The highly saturated <abbr title=\"Cardiac Rhythm Management\">CRM<\/abbr> device market will drive competitors to focus on innovation as a key strategy for growth.<\/strong><\/p>\n<p>Which segments are saturated, and which segments continue to see dynamic growth?<\/p>\n<p>How do epidemiological trends and new technology influence growth in different pulse generator product segments?<\/p>\n<p>How can individual competitors realize growth in this large but fairly mature market?<\/p>\n<p><b>Adoption of novel devices will offset waning revenue for traditional devices in the European <abbr title=\"Cardiac Rhythm Management\">CRM<\/abbr> market.<\/b><\/p>\n<p>What is the predicted uptake of novel devices such as leadless pacemakers and <abbr title=\"Subcutaneous Implantable Cardioverter Defibrillator\">S-<\/abbr><abbr title=\"Subcutaneous Implantable Cardioverter Defibrillator\">ICD<\/abbr>s? Will leadless pacemakers and <abbr title=\"Subcutaneous Implantable Cardioverter Defibrillator\">S-<\/abbr><abbr title=\"Subcutaneous Implantable Cardioverter Defibrillator\">ICD<\/abbr>s become the standard of care?<\/p>\n<p>To what extent will the uptake of leadless pacemakers and <abbr title=\"Subcutaneous Implantable Cardioverter Defibrillator\">S-<\/abbr><abbr title=\"Subcutaneous Implantable Cardioverter Defibrillator\">ICD<\/abbr>s offset declining revenue in other markets?<\/p>\n<p>How is the emergence of dual-chamber leadless pacemakers expected impact the traditional dual-chamber pacemaker market?<\/p>\n<p><strong>The generation of clinical data will be an important competitive factor for disruptive <abbr title=\"Cardiac Rhythm Management\">CRM<\/abbr> devices.<\/strong><\/p>\n<p>Which key ongoing clinical trials are likely to influence the <abbr title=\"Cardiac Rhythm Management\">CRM<\/abbr> device market?<\/p>\n<p>How will the market share dynamics in different device segments be altered by ongoing clinical trials?<\/p>\n<p><strong>The competitive landscape in the European <abbr data-abbreviation-entity=\"9036\" title=\"Cardiac Rhythm Management\">CRM<\/abbr> device market is evolving.<\/strong><\/p>\n<p>Which competitors are positioned to gain market share with new devices, and how will they influence the market&#8217;s future landscape?<\/p>\n<p>What is the predicted uptake of novel devices such as leadless pacemakers and <abbr title=\"Subcutaneous Implantable Cardioverter Defibrillator\">S-<\/abbr><abbr title=\"Subcutaneous Implantable Cardioverter Defibrillator\">ICD<\/abbr>s?<\/p>\n<p>How have innovations influenced <abbr title=\"Cardiac Rhythm Management\">CRM<\/abbr> market share dynamics, and what strategies can competitors adopt to sustain or enhance their positions?<\/p>\n","protected":false},"template":"","class_list":["post-193388","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiac-rhythm-management-devices","medtech-therapy-area-cardiovascular","medtech-geography-europe","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/193388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/193388\/revisions"}],"predecessor-version":[{"id":422800,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/193388\/revisions\/422800"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=193388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}